CUMULUS NEUROSCIENCE
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.
CUMULUS NEUROSCIENCE
Industry:
Health Care
Founded:
2015-01-01
Address:
Belfast, Belfast, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cumulusneuro.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)28 9264 6600
Email Addresses:
[email protected]
Total Funding:
6 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
HealthVerity
HealthVerity powers the discovery, licensing, and linkage of traditional and emerging healthcare data.
Oviva
Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform.
Current Employees Featured
Founder
Investors List
UK Future Fund
UK Future Fund investment in Venture Round - Cumulus Neuroscience
LifeArc
LifeArc investment in Venture Round - Cumulus Neuroscience
Dementia Discovery Fund
Dementia Discovery Fund investment in Venture Round - Cumulus Neuroscience
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-10 | Cumulus Neuroscience appoints Siggi Saevarsson as COO |
Official Site Inspections
http://www.cumulusneuro.com Semrush global rank: 6.85 M Semrush visits lastest month: 744
- Host name: server-18-173-166-125.mia3.r.cloudfront.net
- IP address: 18.173.166.125
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cumulus Neuroscience"
Cumulus Neuroscience - Crunchbase Company Profile …
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.See details»
Cumulus Neuroscience - LinkedIn
We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next …See details»
Overview, News & Similar companies - ZoomInfo.com
Feb 3, 2024 View Cumulus Neuroscience (www.cumulusneuro.com) location in United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Cumulus Neuroscience - Craft
Cumulus Neuroscience (formerly known as BrainWaveBank) is a neurotechnology company that develops a brain physiology analysis tool for the pharmaceutical sector. It offers a …See details»
Locations - Cumulus Neuroscience
At Cumulus Neuroscience, we develop cutting edge technologies for at-home assessment of brain and mental health conditions. With our AI-powered digital health platform and wearable …See details»
Cumulus Neuroscience - 2025 Company Profile - Tracxn
Mar 28, 2025 Cumulus Neuroscience is a series A company based in Belfast (United Kingdom), founded in 2015 by Ronan Cunningham, Brian Murphy, Siggi Saevarsson and Urs Markus …See details»
Cumulus Neuroscience Company Overview, Contact Details
Learn more about Cumulus Neuroscience's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Cumulus Neuroscience Receives FDA 510(k) Clearance for Award …
May 4, 2023 Designed for self-directed use in a patient's home or a healthcare facility, the Cumulus EEG device is now FDA-cleared for use by adult and adolescent patients for the …See details»
Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual …
Apr 4, 2025 Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater separation with …See details»
Cumulus secures FDA 510 (k) approval for at-home EEG platform
May 5, 2023 Cumulus Neuroscience, a digital health company focused on neuroscience, has received the US Food and Drug Administration (FDA) 510 (k) approval for its novel dry-sensor …See details»
Cumulus Neuroscience
The pharmaceutical industry faces a major challenge which has limited the ability to develop effective new drugs for CNS disorders. A session at the Dementia Discovery Fund’s Annual …See details»
A unique career - Cumulus Neuroscience
Cumulus is a world-class neuroscience company offering great opportunities for growing and developing your career. If you are passionate about developing and deploying cutting edge …See details»
Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual …
Apr 4, 2025 To learn more, visit www.cumulusneuro.com. About Alzheimer's Disease and pTau217 Alzheimer's is a progressive disease that affects brain function, memory, and other …See details»
Cumulus Neuroscience
29th April 2025 Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim and Cumulus Neuroscience launch first of its kind study investigating the day-to-day …See details»
Cumulus Neuroscience
Feb 1, 2023 This announcement signifies a profound chapter for Cumulus as it accelerates its biopharma commercialization strategies. “With neuropsychiatric and neurodegenerative …See details»
OHSU discovery suggests new avenue for repairing brain function
2 days ago The study reveals the organization of a specific type of glutamate receptor — a chemical neurotransmitter that conveys signals between neurons and is considered the …See details»
Current job openings - Cumulus Neuroscience
At Cumulus Neuroscience, we develop cutting edge technologies for at-home assessment of brain and mental health conditions. With our AI-powered digital health platform and wearable …See details»
Cumulus Neuroscience
Aug 1, 2024 Cumulus Neuroscience presented data from their real-world feasibility study CNS-101 at the Alzheimer’s Association International Conference 2024 in Philadelphia, …See details»
Cumulus Neuroscience
We are pleased to announce the completion of patient enrollment for our CNS-101 multi-site study. The real-world study evaluates the feasibility of using repeated sampling of validated …See details»
Cumulus Neuroscience
First published: 25th June 2021 Cumulus Neuroscience has published a paper researching the feasibility of at-home EEG assessment, a core component of the Company’s digital CNS …See details»